AXA S.A.

SEC CIK: 0000898427
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by AXA S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overview All 13F holders of ALLO Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of ALLO by AXA S.A., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−28,300−100.0%	Sold out	Holders
Q2 2023	28,300	$140.7K	<0.1%	+28,300	New	Holders
Q1 2023	0	$0	0.0%	−337,400−100.0%	Sold out	Holders
Q4 2022	337,400	$2.12M	<0.1%	+337,400	New	Holders